Investors Should Take Note Of Cellectar Biosciences Inc (CLRB)
Cellectar Biosciences Inc (CLRB) concluded trading on Thursday at a closing price of $0.31, with 6.14 million shares of worth about $1.9 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -86.83% during that period and on December 26, 2024 the price saw a […]
Is There More Upside Ahead For Cellectar Biosciences Inc (NASDAQ: CLRB)
Cellectar Biosciences Inc (CLRB) concluded trading on Wednesday at a closing price of $0.25, with 4.34 million shares of worth about $1.08 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -91.11% during that period and on December 18, 2024 the price saw a […]
Assessing Whether Cellectar Biosciences Inc (NASDAQ: CLRB) Is Over- Or Undervalued
Cellectar Biosciences Inc (CLRB) concluded trading on Wednesday at a closing price of $0.31, with 37.84 million shares of worth about $11.73 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -90.83% during that period and on December 11, 2024 the price saw a […]
Cellectar Biosciences Inc (CLRB) Volatility Spurs A Quest For Clarity
AIGH Capital Management LLC recently announced the acquisition of new stake in Cellectar Biosciences Inc (NASDAQ:CLRB). The institutional investor has increased its shareholding in the Healthcare company by 182.68% to 1.92 million shares with purchase of 1.24 million shares. This fresh investment now brings its stake to 9.93% valued currently at $4.73 million. In addition, […]
